NJ

Niranjanrao Janardhanrao Errabelli

Director Director DIN 02551081
DIN 02551081 First appointment Apr 1995 Primary industry Infrastructure and Utilities
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 1995
Shareholding value •••• Premium profile

About Niranjanrao Janardhanrao Errabelli

Data last updated:

Niranjanrao Janardhanrao Errabelli was a Director at Synapse Drugs Private Limited (2014–2025) and Whole-Time Director at Smruthi Organics Ltd (1995–2011). The companies operate in Infrastructure and Utilities and Pharma.

DIN 02551081
Primary Designation Director
Industry Infrastructure and Utilities
First Appointment 26 Apr 1995

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synapse Drugs Private Limited U24232TG2014PTC096661
Director03 Dec 20142014Under Process Of Striking Off
Smruthi Organics Ltd L24119PN1989PLC052562
Whole-Time Director26 Apr 19951989₹126 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Synapse Drugs Private Limited
Smruthi Organics Ltd
Premium access

Shareholding and investment profile for Niranjanrao Janardhanrao Errabelli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niranjanrao Janardhanrao Errabelli

Niranjanrao Janardhanrao Errabelli was first appointed on 26 Apr 1995 as Whole-Time Director at Smruthi Organics Ltd. The most recent appointment on record is 03 Dec 2014 at Synapse Drugs Private Limited.

Niranjanrao Janardhanrao Errabelli held 2 earlier board appointments: Synapse Drugs Private Limited (Director, 03 Dec 2014 to 08 Nov 2025); Smruthi Organics Ltd (Whole-Time Director, 26 Apr 1995 to 23 May 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available